Polypeptide Electrospun Nanofibrils for Tissue Engineering
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing polymer nanofibrils lack guidance on conditions for making nanofibrils of defined composition and properties, limiting their spinnability and functional applications in medical and bioscience fields.
Innovation Solution
The development of polypeptide electrospun nanofibrils through dissolving polypeptides in solvents and electrospinning them to form nanofibrils, which can be cross-linked and used in various applications due to their high surface area and porosity, mimicking the extracellular matrix for controlling cell behavior.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Strength
If conventional polymer fibers with diameters of 50 microns or greater are used, then structural strength and ease of manufacture are improved, but flexibility and surface area are reduced
Solution Approach 1:
The patent segments the fiber structure by creating hierarchical levels of fibrous assemblies, where individual nanofibrils (1-100 nm) are bundled into larger fibrous assemblies (1-100 microns), which can further be assembled into macroscopic structures. This segmentation allows each level to contribute different properties: nanofibrils provide high surface area, while bundled assemblies provide structural strength.
Solution Approach 2:
The patent transitions from conventional single-scale fibers to multi-scale fibrous assemblies by adding dimensional hierarchy. Individual nanofibrils at the nanoscale provide surface area, while their organization into micron-scale bundles and macro-scale assemblies provides structural dimensions, effectively utilizing multiple spatial dimensions to resolve the contradiction.
2Area of moving object
If polymer nanofibrils with diameters in the nanometer to low micron range are used, then surface area and flexibility are improved, but structural strength and ease of manufacture are reduced
Solution Approach 1:
The patent employs self-assembly mechanisms where polypeptide solutions spontaneously form nanofibrillar structures through electrospinning or self-organization processes. The polypeptides inherently direct their own assembly into nanofibrils with controlled morphology, eliminating the need for complex external manufacturing interventions and simplifying production.
Solution Approach 2:
The patent controls nanofibril formation by adjusting solution parameters such as polypeptide concentration, solvent composition, pH, and electrospinning conditions. By optimizing these parameters, the manufacturing process achieves consistent nanofibril production with desired properties, making the process both precise and scalable.
3Adaptability or versatility
If polypeptides are used to form nanofibrils, then biodegradability and biofunctionality are improved, but control over composition and properties is reduced
Solution Approach 1:
The patent creates composite fibrous assemblies by combining different polypeptides, polypeptides with synthetic polymers, or incorporating bioactive molecules within the nanofibril structure. This composite approach allows simultaneous achievement of biodegradability from polypeptides, mechanical properties from synthetic components, and controlled composition through the composite architecture.
Solution Approach 2:
The patent implements local quality control by incorporating different polypeptide sequences, amino acid compositions, or bioactive motifs at specific locations within the nanofibril structure. This allows different regions of the same fibrous assembly to have tailored properties for specific functions while maintaining overall structural integrity.
4Length of moving object
If existing polymer nanofibrils are used, then nanoscale dimensions are achieved, but defined composition and controlled properties are not obtained
Solution Approach 1:
The patent incorporates feedback mechanisms in the polypeptide synthesis and processing steps, where the composition and properties of the resulting nanofibrils are monitored and used to adjust subsequent manufacturing parameters. This closed-loop control ensures consistent achievement of defined composition and desired properties in the final product.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method enables the production of electrospun nanofibrils with controlled properties, suitable for biomedical applications, such as tissue engineering and drug delivery, by leveraging the biofunctionality and biodegradability of polypeptides, enhancing cell migration and proliferation.
Implementation Method 1
electrospinning the solution to form the electrospun nanofibril
Data Source
AI summary
Electrospun nanofibrils and methods of preparing the same are provided. The electrospun nanofibrils comprise at least one polypeptide. A polypeptide can be dissolved in a solution, and the solution can be electrospun into a nanofibril. The solution can be added to a syringe or syringe pump, and an electric field can be applied to electrospin the at least one polypeptide.